MENUNews Archive
Date: 08/26/2019
Since 2012, Michigan Drug Discovery has invested more than $2.3 million in more than 70 projects. Now, they are funding three projects led by Rogel Cancer Center researchers. Each project is looking to find new treatments for cancer.
Date: 08/24/2019
A clinical trial testing a new pancreatic cancer drug had promising initial results, say University of Michigan Rogel Cancer Center researchers in the Journal of Clinical Oncology. Investigators ran a phase 1 clinical trial that looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in repairing damaged DNA. The trial builds on almost 20 years of research at U-M focused on improving the treatment of pancreatic cancer cases that are too advanced for surgery.
Date: 07/31/2019
The University of Michigan Rogel Cancer Center continues to be ranked best in Michigan in the 2019-20 U.S. News & World Report “Best Hospitals” rankings, an honor that measures excellence in patient care.
Date: 07/24/2019
A new survey by researchers at the U-M Rogel Cancer Center and Institute for Healthcare Policy and Innovation suggests many patients are receiving the treatment when there’s no strong indication of benefit.
Date: 07/15/2019
A new way to cleanly separate out cancer cells from a blood sample enables comprehensive genetic profiling of the cancer cells, which could help doctors target tumors and monitor treatments more effectively.
Date: 07/15/2019
Large randomized clinical trials can uncover biomarkers to identify which cancer treatments are likely to work best for individual patients.
Date: 07/01/2019
A new study from researchers at the University of Michigan Rogel Cancer Center finds that the gene FOXA1 overrides normal biology in three different ways to drive prostate cancer. They refer to the three classes as FAST, FURIOUS, and LOUD to reflect their unique features. The findings are published in Nature.
Date: 07/01/2019
U-M Rogel Cancer Center and College of Engineering researchers found breast cancer cells that swallow up nearby stem cells, making it easier for them to invade other tissues and seed secondary tumors.
Date: 06/30/2019
Black men are more likely to be diagnosed with prostate cancer and nearly 2.5 times more likely to die of the disease compared to non-Hispanic white men. The question is why. Are black men more likely to carry genes that drive deadlier forms of the disease? What societal disparities might be affecting outcomes?
Date: 06/19/2019
Cancer is not simply masses of cells but structured organs with multiple cell types that communicate with each other and interact with the body -- much like your lungs or liver.